Title
A Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemi
Code
CL , 3-95031-007 (CHONQUER)
Type
Sperimentale
Start Year
2025
Status
In Corso
Principal Investigator
051-6365503
giorgio.frega@ior.it
Operational unit that carry out the study
complex unit
Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative
Director
:Description
Studio clinico promosso da Institut de Recherches Internationales Servier (I.R.I.S.).
Documents and Videos attachament
Attachment
PG0000329_2025_Nulla osta DG.pdf
Nulla osta alla conduzione dello studio prot. CL , 3-95031-007 (CHONQUER).